SEC Form 4 · accession 0001682806-16-000003
SEATTLE GENETICS INC /WA · SGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Dobmeier
Officer — Chief Operating Officer
Period of report
Aug 23, 2016
Accepted (ET)
Aug 24, 2016 · 6:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001060736
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 23, 2016 | M | 3,831 | $26.10 | A | 71,356 | D | |
| Common StockF1 | Aug 23, 2016 | S | 12,589 | $48.00 | D | 58,767 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option (right to buy)F2 | $26.10 | Aug 23, 2016 | M | 3,831 | D | — | Aug 20, 2022 | Common Stock | 3,831 | 0 | D |
Explanation of responses
- F1Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
- F2Shares vested at a rate of 25% on August 20, 2013 and monthly thereafter until all the shares were fully vested on August 20, 2016.